Diamond Hill Capital Initiates Position in Elevance Health
Diamond Hill Capital invested in Elevance Health during the second quarter of 2026, citing positive long-term earnings power despite current industry headwinds.
Diamond Hill Capital, a First Eagle Investment Management company, initiated an investment position in Elevance Health, Inc. during the second quarter of 2026. The move was detailed in the investment firm's Q2 2026 investor letter for its Large Cap Strategy.
Diamond Hill Capital identified the company as one of the largest health insurers in the United States. The firm acknowledged that Elevance Health is facing margin pressures caused by rising medical costs and lower government reimbursement, trends affecting the broader insurance industry. Despite these challenges, the investment manager stated that the long-term earnings power of the business remains positive.
As of July 31, 2026, Elevance Health had a share price of $375.84 and a total market capitalization of $81.54 billion.